Hepatitis C and HIV Testing in Residential Treatment: The CDC Screening Rules, the Six-Month Window, and What to Ask Admissions

, ,
Mental Health Rehab San Jose

Most people arriving at residential treatment are focused on getting through detox and the first few days. Bloodwork for hepatitis C and HIV is rarely on their mind, and families often learn about it only when a result comes back and nobody is sure what it means. Yet the intake period is one of the most practical moments in a person’s life to get screened, because a clinical team is already drawing labs, someone is following up, and there is time to start a plan before discharge.

This guide explains what the current federal testing recommendations say, how the tests actually work, where the process tends to break down, and the specific questions to ask admissions before or during the first week. If you want to talk through a specific situation, call our team at (877) 328-1968.

What the CDC Recommends, in Plain Terms

The CDC recommends that every adult 18 and older be tested for hepatitis C at least once in their lifetime, and that everyone between the ages of 13 and 64 be tested for HIV at least once. For people who share needles, syringes or other injection equipment, the CDC recommends HIV testing at least once a year and periodic hepatitis C testing for as long as the risk continues. A person entering residential treatment who has injected drugs even once, even long ago, falls inside the hepatitis C testing recommendation, and a reactive hepatitis C antibody test is not by itself a diagnosis: a second test for the virus itself (an HCV RNA test) is what confirms a current infection. Current hepatitis C treatment can cure most people within 8 to 12 weeks, according to the CDC. (Recommendations checked at CDC hepatitis C testing guidance and CDC HIV testing guidance on October 14, 2026.)

Note that these recommendations are not limited to people who inject. The CDC’s hepatitis C screening recommendation covers all adults, and its HIV recommendation calls for yearly testing for anyone who has exchanged sex for drugs or money, had more than one sex partner since their last test, or been treated for another sexually transmitted infection, hepatitis or tuberculosis. Substance use of any kind can raise those risks, which is why many programs offer screening to everyone rather than only to people who report injection.

How the Tests Work, and Why Results Confuse People

Much of the anxiety around these results comes from not knowing that screening happens in steps. Understanding the sequence prevents a lot of unnecessary fear.

  • Hepatitis C antibody test: shows whether a person has ever been infected, not whether they are infected now, because antibodies stay in the blood even after the virus is cleared or cured.
  • HCV RNA test (nucleic acid test): looks for the virus itself and is what confirms a current infection after a reactive antibody result.
  • Rapid point-of-care tests: use a small blood sample and can return a result in about 30 minutes, per the CDC, but a reactive rapid result still needs lab confirmation.
  • HIV antigen/antibody lab tests: are the type the CDC recommends for lab testing, and they look for both antibodies and the p24 antigen, which can be detected before antibodies develop.
  • Recent exposure: if someone may have been exposed to hepatitis C in the past six months, the CDC says an RNA test should be ordered instead of an antibody test, because antibodies may not have developed yet.

That last point matters in residential treatment specifically. Many people arrive within days or weeks of their last use. A negative antibody test drawn on day two does not rule out an exposure from two weeks earlier, and the care team needs to know about recent risk to choose the right test.

Why the Timing Problem Is the Real Issue

In treatment consultation work, the most common failure we see is not a refusal to test. It is a result that arrives after the person has already left. Send-out lab work, and especially confirmatory RNA testing, can take days to come back. If the person discharges before the follow-up conversation, a reactive result may sit in a chart with no one assigned to act on it.

The second timing gap is treatment length. Hepatitis C treatment typically runs 8 to 12 weeks, which can be longer than a residential stay. That means treatment, if started, usually has to continue with an outpatient prescriber, and the handoff is where people get lost. A residential stay is often the most stable stretch of time a person has had in months, which makes it a good moment to begin, as long as the outpatient prescriber is lined up before discharge.

An honest, inconvenient truth: some programs do not draw these labs on site and instead refer out. That is not automatically a problem, but it means you need to know who owns the follow-up before you arrive.

What to Ask Admissions Before Arrival

These are questions you can ask on your next call with any program, including ours at (877) 328-1968. Write the answers down.

  1. Do you offer hepatitis C and HIV screening during intake, and is it opt-out or by request? Opt-out screening means it is offered to everyone unless the person declines.
  2. Are labs drawn on site, or is the person sent to an outside lab or clinic? This affects how quickly results return.
  3. If an antibody test is reactive, is the confirmatory RNA test run automatically from the same sample? Reflex testing avoids a second blood draw and a delay.
  4. Who reviews the result with the patient, and how fast? Ask for a role, such as the medical director or nurse practitioner, not just “the team.”
  5. If treatment is needed, will it start during the stay, and who prescribes after discharge? Ask whether the outpatient prescriber is named in the discharge plan.
  6. Is the cost covered by insurance or billed separately? Screening is often covered as preventive care, but confirmatory testing and treatment may follow different rules. Our insurance verification page can help you start that check.

Something You Can Do Today

Before admission, gather two pieces of information and give them to the intake nurse: the date of any prior hepatitis C or HIV test and its result, and the approximate date of the most recent possible exposure, such as shared injection equipment or unprotected sex. If you have an old lab report on a patient portal, take a screenshot. That single step lets the clinical team decide between an antibody test and an RNA test on day one instead of discovering the gap a week later.

If you are a family member, you cannot request results without the person’s written consent. Federal confidentiality rules for substance use treatment records are strict. What you can do is encourage your loved one to sign a release that covers medical updates, and ask admissions which form that is.

Safety First During the Early Days

Lab screening is never the priority over a safe withdrawal. Withdrawal from alcohol and benzodiazepines can cause seizures and can be life-threatening, and it requires medical supervision. Anyone with recent heavy use of either substance should be assessed for medically managed detox before or at the start of residential treatment. Opioid withdrawal is rarely fatal by itself, but returning to use after a period of abstinence carries a high overdose risk because tolerance falls quickly. The National Institute on Drug Abuse notes that illicitly manufactured fentanyl now drives most overdose deaths and may be present in other drugs without the buyer knowing.

If you or someone you love is in crisis, call or text 988 to reach the 988 Suicide & Crisis Lifeline. For free, confidential treatment referrals at any hour, the SAMHSA National Helpline is available at 1-800-662-4357.

How This Fits Into a Full Treatment Plan

A positive result for hepatitis C or HIV is news that deserves time and support, and it can be heavy to receive early in recovery. A well-run program treats it as part of the care plan rather than a side issue: counseling staff are aware, the person is not left alone with the result, and the discharge plan names who will carry treatment forward. A negative result is useful too, because it gives a baseline and is a natural moment to talk about prevention, including access to sterile supplies and pre-exposure prophylaxis (PrEP) for HIV where appropriate.

For a broader view of how programs coordinate medical and behavioral care, see our overview of addiction treatment. Our team in Northern California can walk you through what intake looks like, which labs are typically drawn, and what to bring. Call (877) 328-1968 to talk with someone today.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Testing and treatment decisions should be made with a licensed healthcare provider who knows your history. If you are experiencing a medical emergency, call 911.

/by

Alcohol Use Disorder Medications After Residential Treatment: The Three FDA-Approved Options, Timing Rules, and What to Ask Before Discharge

, ,
San Francisco Bay Area addiction treatment consulting and program placement | Bodhi nationwide network

Most people who complete residential treatment for alcohol use disorder leave with a discharge plan that covers therapy, housing, and support meetings. Fewer leave with a clear plan for medication, even though medications approved specifically for alcohol use disorder exist, are not addictive, and can be started or continued after residential care. This guide explains the three options, the timing rules that decide which one fits, and the questions to settle with the treatment team before the discharge date.

The Three FDA-Approved Medications, in One Paragraph

Three medications are approved by the FDA for alcohol use disorder in the United States: naltrexone, acamprosate, and disulfiram. According to the National Institute on Alcohol Abuse and Alcoholism (NIAAA), all three are nonaddictive, and they can be used alone or alongside counseling. Naltrexone comes as a daily pill or as an extended-release injection given every four weeks, and it reduces the urge to drink. Acamprosate is a pill that eases the discomfort some people feel during early abstinence and is usually started a few days after drinking stops. Disulfiram is a daily pill that causes an unpleasant physical reaction if alcohol is consumed. None of the three treats alcohol withdrawal itself, so for a person leaving residential treatment the practical questions are which medication fits their health history, and whether the prescription and the first follow-up appointment are confirmed before discharge.

Withdrawal Comes First, and It Needs Medical Supervision

These medications are for staying stopped, not for stopping. Alcohol withdrawal can cause seizures and delirium tremens, and it requires medical supervision. Anyone who has been drinking daily should not stop abruptly at home and then plan to begin a medication the following week. Withdrawal should be managed in a medically supervised setting, and medication for long-term recovery is typically discussed once that stage is complete. The same seizure risk applies to anyone who is also dependent on benzodiazepines, and those medications should never be stopped suddenly without a prescriber involved.

If you are unsure whether detox needs to come before residential treatment, our admissions team can walk through it with you at (877) 328-1968.

Naltrexone: Timing Rules That Matter

Naltrexone is the medication most people have heard of, and it is often a reasonable first conversation. Two timing rules decide whether it is safe to start.

Opioids in the last two weeks: naltrexone blocks opioid receptors, so starting it while opioids are still in the body can bring on sudden withdrawal. SAMHSA’s guidance on naltrexone describes waiting at least 7 days after the last use of short-acting opioids and 10 to 14 days after long-acting opioids. That includes prescribed pain medication and opioid-containing cough or diarrhea medicine, not just illicit drugs.

Physical dependence on alcohol: SAMHSA notes that a person starting naltrexone for alcohol use disorder must not be physically dependent on alcohol, which is why it is usually started after detox.

One safety point deserves to be stated plainly. A person who has stopped using opioids while on naltrexone has lower tolerance. If they stop the medication and return to opioid use, a dose they once handled can be life-threatening. Anyone with a history of opioid use should leave treatment with naloxone and know how to use it.

The injectable form is given every four weeks by a clinician. For some people that removes the daily decision to take a pill, but it also means the next injection appointment has to be booked before discharge, not after.

Acamprosate: Often the Option When Others Are Ruled Out

SAMHSA describes acamprosate as well tolerated, with no potential for misuse and no clinically significant drug interactions. It can be used alongside psychiatric medications and can be continued if a person returns to drinking. It is also often considered for people who cannot take naltrexone because of liver disease or because they are being treated with opioids, including buprenorphine or methadone.

The main exclusion is the kidneys. Acamprosate should not be started in severe kidney disease, so recent kidney function labs are part of the decision. If those labs were drawn during residential care, ask for a copy to go with your discharge paperwork.

Disulfiram: Effective Only With a Clear Agreement

Disulfiram works differently. It does not reduce cravings. According to SAMHSA, it causes flushing, nausea, vomiting, palpitations, and other symptoms when alcohol enters the body, beginning about 10 minutes after drinking. It should not be taken for 12 to 48 hours after drinking, and a reaction can still occur for up to two weeks after the last dose. Alcohol hidden in mouthwash, cough syrup, sauces, vinegars, and some baked goods can trigger it.

Because of this, disulfiram suits people whose goal is complete abstinence and who want a firm external commitment. SAMHSA notes it may work better when a family member or provider observes the daily dose. That arrangement has to be agreed to openly. Disulfiram must never be given to someone without their knowledge. It is also not appropriate for people with severe heart disease, severe liver disease, or a history of psychosis.

Why Medication Plans Fall Apart After Discharge

From the discharge-planning side of residential care, the problem is rarely that the wrong medication was chosen. It is usually logistics. These are the gaps that come up most often:

  • The prescription runs out before the first appointment: a person leaves with a short supply, and the first outpatient prescriber visit is weeks away.
  • No named prescriber: the discharge summary says “continue naltrexone” but does not say who will write the next prescription.
  • The injection is not scheduled: the four-week injectable needs a booked appointment and, often, insurance approval in advance.
  • The pharmacy does not stock it: acamprosate and the injectable form are not always on the shelf, so the first fill can be delayed.
  • Family is not briefed: with disulfiram in particular, the people at home need to know about hidden alcohol and what a reaction looks like.

None of these require a clinical decision. Each is a phone call that is far easier to make while the person is still in residential care, with staff and records in the same building.

Five Questions to Ask Before the Discharge Date

Bring this list to your next treatment team meeting or discharge planning session, and write the answers down:

  1. Which of the three medications was considered for me, and why was it chosen or ruled out?
  2. Who is my prescriber after discharge, and what is the date of the first appointment?
  3. How many days of medication am I leaving with, and does that cover the time until that appointment?
  4. Has my pharmacy confirmed it has the medication, and has my insurance approved it?
  5. Which labs (liver or kidney function) were done here, and will a copy go to my next provider?

If the answer to any of these is “we’ll figure that out later,” that is the item to resolve first. If you are stepping down to an outpatient program, confirm whether that program has its own prescriber or whether you need a separate one.

Insurance and Cost

Coverage for these medications varies by plan, and the injectable form in particular may require prior authorization. Ask the treatment team to start that request before discharge rather than after. If you are still deciding on care, you can verify your insurance with us, or call (877) 328-1968 to talk through what your plan is likely to cover.

Medication Is One Part of the Plan

NIAAA and SAMHSA both describe these medications as one component of treatment, used together with counseling and ongoing support. They do not cure alcohol use disorder, and they work best when someone is checking in regularly. A return to drinking while on naltrexone or acamprosate is a reason to call the prescriber, not a reason to stop the plan. If you are a family member, the most useful thing you can do is make sure the five questions above have written answers before your loved one comes home.

If you or someone you love needs help with alcohol use in Northern California, call Bodhi Addiction Treatment at (877) 328-1968. If someone is in immediate danger, call 911. For a mental health or suicidal crisis, call or text 988.

This article is for educational purposes only and is not medical advice. Do not start, stop, or change any medication without talking to a licensed prescriber. Alcohol and benzodiazepine withdrawal can be life-threatening and require medical supervision.

/by

Job-Protected Leave for Residential Treatment in California: FMLA, CFRA, the 12-Week Limit, and What to Ask Admissions

,
A professional working on a laptop indoors — executive residential rehab remote-work track

For many working adults, the question that delays residential treatment is not “do I need help?” It is “will I still have a job when I get back?” In our consulting work, we regularly speak with people who are ready to go but are stuck on a conversation with HR they have not had yet. This guide explains how job-protected medical leave works for substance use treatment in California, what the numbers are, and what to ask admissions and your employer before your first day.

The Short Answer: Federal FMLA and California CFRA

Under the federal Family and Medical Leave Act (FMLA) and the California Family Rights Act (CFRA), an eligible employee in California can take up to 12 workweeks of job-protected, unpaid leave in a 12-month period for treatment of a serious health condition, and the U.S. Department of Labor’s FMLA regulations state that treatment for substance use by a health care provider, or on referral by one, can qualify. Absence caused by the use of a substance itself does not qualify. To be eligible, an employee generally must have worked for the employer for at least 12 months and at least 1,250 hours in the 12 months before leave. FMLA applies to employers with 50 or more employees within 75 miles of the worksite; CFRA, since 2021, applies to California employers with 5 or more employees.

That paragraph is the core of it. The leave is usually unpaid, which is why many people pair it with California State Disability Insurance, but the job protection and continuation of group health coverage are what most people are really worried about.

What “Job-Protected” Does and Does Not Mean

Protected leave means your employer must generally restore you to the same or an equivalent position when you return, and must keep your group health insurance on the same terms while you are out. It does not mean every workplace consequence disappears. Understanding the limits matters:

  • Treatment is protected, use is not: the federal rules protect absence for treatment, not absence caused by drinking or using.
  • Existing policies still apply: an employer may act under a substance use policy that was established, communicated, and applied uniformly before the leave, even if the employee is on FMLA leave.
  • Prior discipline is not erased: taking leave does not cancel performance or attendance issues already documented before you asked for it.
  • Safety-sensitive roles have extra rules: commercial drivers, pilots, and some healthcare and transit workers fall under separate testing and return-to-duty requirements that leave law does not override.

If any of these apply to you, it is worth a short consultation with an employment attorney or your union representative before you file. We are not lawyers, and the specifics of your workplace policy matter.

The Paperwork, Step by Step

The process is more procedural than most people expect. In general terms, it runs like this:

  1. Give notice. When treatment is foreseeable, the rules call for 30 days’ notice. When it is not, such as an admission scheduled within days, you give notice as soon as practicable, usually the same or next business day. You do not need to name the diagnosis to start the process; saying you need medical leave for a serious health condition is enough.
  2. Watch for the eligibility notice. Under the federal regulations, the employer generally has 5 business days to tell you whether you are eligible and what certification is required.
  3. Return the medical certification. You are typically given at least 15 calendar days to return a certification form completed by a health care provider. HR receives the certification of need, not your full treatment record.
  4. Confirm health coverage and return date. Ask in writing how premiums will be handled while you are on leave and what return-to-work documentation, if any, will be required.

Medical information you give your employer for leave purposes must be kept confidential and separate from your general personnel file. Separately, federal confidentiality rules for substance use treatment records mean the treatment program cannot share information with your employer unless you sign a specific consent.

What We See Go Wrong: The Certification Gap

The most common practical problem we see is timing. A person finds a bed, schedules admission for later in the week, and gives HR notice. HR sends a certification form. Then the question becomes: who fills it out? The outpatient physician who has not seen the person in a year may decline. The residential program has not yet assessed the person and cannot certify a condition it has not evaluated. The form sits.

The fix is simple, and it is the instruction we give most often: on your admissions call, ask, “Who on your clinical team completes FMLA and CFRA certification forms, and how quickly after admission?” Many residential programs handle these routinely once the intake assessment is done. Knowing the name of that person and the expected turnaround lets you tell HR the form is coming, rather than going silent while you settle in. You can reach our team at (877) 328-1968 to talk through what to ask a specific program.

A second gap: people often start leave before the program’s start date and spend the waiting days alone and unsupported. If you are physically dependent on alcohol or benzodiazepines, do not stop abruptly while you wait for admission. Withdrawal from these substances can cause seizures and can be life-threatening, and it requires medical supervision. Tell admissions exactly what and how much you use so they can determine whether medically supervised detox is needed first.

How Long Leave Fits With How Long Treatment Takes

Twelve workweeks is a ceiling, not a target. Residential length of stay is set by clinical need and, if insurance is involved, by the payer’s review of medical necessity. The ASAM Criteria are the framework most programs and insurers use to match a person to a level of care and to decide when to step down. The National Institute on Drug Abuse’s principles of effective treatment emphasize that remaining in treatment for an adequate period is important to outcomes, and that recovery often involves continuing care after the most intensive phase.

In practice, that means planning leave for the full arc, not just the residential stay. Leave can often be taken intermittently or on a reduced schedule when medically necessary, which can be useful for stepping down to a partial hospitalization program or outpatient treatment while gradually returning to work. Ask your employer, in writing, whether a reduced schedule is available after discharge.

Questions to Ask Before Admission

Ask the admissions team:

  • Who completes FMLA/CFRA certification, and how soon after intake?
  • What is the expected length of stay, and how is it reviewed?
  • Will you provide a discharge letter or return-to-work note if my employer requires one?
  • Which consent forms will I need to sign if I want you to confirm dates to my HR department, and can I limit what is shared?

Ask your employer or HR:

  • Am I eligible under FMLA, CFRA, or both, and when does my 12-month period reset?
  • How will my health insurance premiums be collected while I am on leave?
  • Do I need to use accrued paid time off at the same time?
  • Is there an Employee Assistance Program that can help coordinate?

For a broader overview of how to find and compare care, the SAMHSA National Helpline is free, confidential, and available 24 hours a day at 1-800-662-4357.

Where Bodhi Fits In

Bodhi Addiction Treatment & Wellness helps people in Northern California find and enter the right level of care, including residential treatment. Part of that work is the unglamorous logistics described above: confirming admission dates that line up with leave paperwork, identifying who will complete forms, and planning step-down care so the return to work is gradual rather than abrupt. If you are weighing treatment against your job, call (877) 328-1968 and we can walk through your situation, or start by verifying your insurance.

If you or someone you know is in immediate danger or thinking about suicide, call or text 988, or call 911.

This article is for educational purposes only and is not medical, legal, or employment advice. Leave eligibility depends on your employer, your work history, and your specific circumstances, and rules can change. Confirm details with your employer, a qualified employment attorney, or the U.S. Department of Labor and California Civil Rights Department. Withdrawal from alcohol or benzodiazepines can be dangerous and should be managed under medical supervision.

/by

State Disability Insurance During Residential Treatment in California: The 49-Day Filing Window and What to Ask Admissions

,
A physician working at a desk with laptop and phone — choosing a residential rehab program

Most families who call us about residential treatment ask about insurance first. The second question, usually a day or two later, is quieter: how do we pay the rent while he is away? For many working Californians, part of the answer is State Disability Insurance (SDI), the wage-replacement program run by the Employment Development Department (EDD). It is funded through the payroll deduction labeled CASDI or SDI on most California pay stubs, and a large share of people entering treatment have been paying into it for years without ever using it.

This guide covers how SDI fits around a residential treatment stay, the filing window that catches people out, and what to sort out with admissions before the bed date. It is written from the placement side of the process, where we see which claims go smoothly and which ones stall.

SDI During Residential Treatment: The Short Version

California State Disability Insurance can partially replace wages for an eligible worker who is unable to do their regular work because of a medical condition, and a substance use disorder that requires residential treatment can be that condition when a licensed health professional certifies it. The SDI claim must be filed no earlier than 9 days and no later than 49 days after the disability begins, the first 7 days are an unpaid waiting period, and benefits can last up to 52 weeks. SDI replaces part of a paycheck; it does not protect the job, which is a separate matter handled through FMLA or CFRA leave.

Those figures come from EDD’s published Disability Insurance rules, which you can read on EDD’s Disability Insurance pages. Benefit amounts depend on your earnings in a past base period, so the only reliable number for your situation is the one EDD calculates. Eligibility rules change from time to time, so confirm the current rules with EDD before you budget around a payment.

SDI Is Not Job Protection

This is the misunderstanding we correct most often. SDI is money. It says nothing about whether your position is held for you. Job protection comes from the federal Family and Medical Leave Act and California’s CFRA, which provide up to 12 workweeks of job-protected leave for eligible employees, described on the U.S. Department of Labor’s FMLA page. California law also requires many employers to reasonably accommodate an employee who voluntarily enters an alcohol or drug rehabilitation program.

In practice, most people need both: a leave request to HR so the job is protected, and an SDI claim to EDD so some income continues. They are two different agencies, two different forms, and two different clocks. Filing one does not file the other.

Why SDI Claims Stall During Residential Treatment

When an SDI claim tied to treatment goes wrong, it is rarely because the person was ineligible. It is almost always logistics. These are the patterns we see:

  • The 49-day deadline: The window opens on day 9 and closes on day 49 after the disability begins, and a claim filed late can lose benefits unless EDD accepts a good-cause reason.
  • Limited device access in the first week: Many residential programs restrict phones and laptops early in a stay, so a person who planned to “file from treatment” may not have the access they expected when the window opens.
  • No one assigned to certify: The claim needs medical certification from a licensed health professional, and if nobody at the program has been told to expect the request, it can sit unanswered.
  • A missing receipt number: When the claim is filed online through SDI Online, EDD issues a receipt number that the certifying provider uses to complete their part, and that number often ends up in a notebook in the person’s locked bag.
  • Self-employment: People who work for themselves are generally not covered by SDI unless they bought into EDD’s elective coverage, and they often discover this only after admission.

None of these require the person in treatment to do anything heroic. They require someone to plan the paperwork before admission day, not after.

What to Do Today, Before the Bed Date

You can do each of these in under an hour:

  1. Check a recent pay stub. Look for a deduction labeled CASDI, SDI, or a similar state disability line. If it is there, you have been paying into the program. If you are self-employed or your employer uses a voluntary plan, ask HR or EDD which coverage applies to you.
  2. Write down the start date. The disability begin date is usually the admission date, or the start of a medically supervised detox if that comes first. Count forward 9 days and 49 days and put both dates in a calendar that someone at home can also see.
  3. Ask admissions three specific questions. “Who on your team completes the medical certification for an SDI claim?” “Will the person have supervised access to a phone or computer between day 9 and day 49 to file or check the claim?” “Have you completed SDI certifications for other clients?” A program that has done this before will answer quickly.
  4. Talk to HR separately. Request FMLA or CFRA leave in writing and ask what paid time off, short-term disability, or other benefits may run alongside SDI. Keep a copy.
  5. Decide who holds the paperwork at home. Choose one trusted person to track the receipt number, deadlines, and EDD correspondence, and make sure the person in treatment has signed whatever release the program needs to talk with them.

If you are not sure whether residential care is the right level, or whether a program near you handles this paperwork well, our treatment consultants can walk through it. Call (877) 328-1968.

What Week One Usually Looks Like on the Paperwork Side

The first several days of residential care are built around medical stabilization, sleep, assessment, and orientation. People are tired and often irritable, and administrative tasks are the last thing on their mind. That is normal, and it is one reason the SDI window opening on day 9 tends to work in the person’s favor: by then most people are sleeping better, attending groups, and able to sit with a case manager for twenty minutes to finish a claim.

What families tend to observe is a short, flat phone call in week one, then a more engaged person in week two who suddenly remembers the bills. That second call is the right moment to confirm the claim has been filed and that the certifying provider has the receipt number.

A Safety Note on Detox Timing

Some people try to delay admission so their leave and SDI dates line up neatly, or they try to stop drinking at home on their own first so they arrive “ready.” If alcohol or benzodiazepines are involved, stopping suddenly can cause seizures and other serious complications, and withdrawal from either requires medical supervision. Paperwork can be filed late with good cause; a withdrawal seizure cannot be undone. Never time a detox around a benefits deadline.

Research summarized by the National Institute on Drug Abuse emphasizes that remaining in treatment for an adequate period of time matters for outcomes. Financial pressure is one of the most common reasons people leave residential care early, which is why sorting out wage replacement before admission is clinical work, not just administration.

When Money Is Still the Barrier

SDI replaces only part of a paycheck, and not everyone qualifies. If cost is what is stopping someone from entering care, start with a benefits check through our insurance verification page, and ask any program about payment options in writing. The SAMHSA National Helpline is free, confidential, and can point people toward state-funded treatment options. Level-of-care decisions should be based on clinical need, which programs commonly assess using the ASAM Criteria, rather than on what feels affordable this week.

If you want help thinking through timing, leave, and placement together, call our team at (877) 328-1968. We work with families across Northern California every week on exactly this sequence.

If you or someone you know is in immediate danger or experiencing a mental health crisis, call or text 988 to reach the Suicide and Crisis Lifeline, or call 911.

This article is for educational purposes only. It is not legal, tax, financial, or medical advice, and it does not determine eligibility for any benefit. State Disability Insurance eligibility, benefit amounts, and filing rules are set by the California Employment Development Department and may change; confirm current requirements directly with EDD and your employer. Withdrawal from alcohol or benzodiazepines can be medically dangerous and should be managed under medical supervision.

/by

Drug Testing in Residential Treatment: What the Standard Panel Misses, Fentanyl, and What to Tell Admissions

,
A quiet clinical exam room — residential care for post-acute withdrawal syndrome (PAWS)

Almost every residential program in California collects a urine sample on admission day, and most keep testing throughout the stay. People arriving for treatment often worry about what a drug test means for them: whether a positive result will get them turned away, whether their family will be told, and whether a prescription will look like a relapse. This guide explains how drug testing actually works in residential treatment, what the standard panels do and do not detect, and what to tell admissions before you arrive.

Why Residential Programs Test on Admission

An admission drug test is a clinical safety tool, not an entry exam. Its job is to tell the medical team what is in a person’s system so withdrawal can be anticipated and managed. The American Society of Addiction Medicine describes drug testing as part of clinical care that should support treatment rather than punish patients (see ASAM clinical guidelines). In practice, a positive result on day one is expected. It is the reason the person is there.

What the result changes is the medical plan. A positive for benzodiazepines, alongside a history of daily alcohol use, tells the nursing team that withdrawal could involve seizures. Alcohol and benzodiazepine withdrawal can cause seizures and must be medically supervised. Never stop either one abruptly on your own in the days before admission to “test clean.” Stopping suddenly is more dangerous than arriving with the substance still in your system.

What a Standard Urine Panel Detects and What It Misses

Most residential programs start with a rapid immunoassay cup or a lab-based screen, then send any unexpected result for confirmation. A standard federal workplace drug test covers five drug classes: marijuana, cocaine, opioids, amphetamines, and phencyclidine (PCP), under rules overseen by SAMHSA’s workplace drug testing program. Treatment programs usually test for more than that, but the gaps in a basic panel matter for anyone with a fentanyl, oxycodone, or prescription history.

A standard opiate screen in a residential drug test is built to detect morphine and codeine, so it can miss fentanyl, oxycodone, buprenorphine, and methadone unless the program runs a separate test for each one. Fentanyl in particular needs its own assay. A person who used only fentanyl can screen negative for “opiates” on a basic cup while being physically dependent and at real risk of withdrawal. Before admission, ask the program directly whether its panel includes fentanyl.

The reasons a basic screen produces surprising results fall into a few clear categories:

  • Structural mismatch: Synthetic and semi-synthetic opioids such as fentanyl and oxycodone are shaped differently from morphine, so the opiate antibody in a basic cup often does not react to them.
  • Contaminated supply: Fentanyl is found mixed into counterfeit pills and other drugs, so a person can test positive for a substance they never knowingly took. NIDA describes this contamination of the illicit supply.
  • Cross-reactivity: Some prescription and over-the-counter medications can trigger a presumptive positive on an immunoassay. That is why a screen result is treated as preliminary until a lab confirms it.
  • Detection window: A negative only means the substance is not detectable now. It does not mean the person has not been using.

Detection Windows: Commonly Cited Ranges

How long a substance shows up in urine depends on the amount used, how often, body composition, hydration, kidney and liver function, and the test itself. The ranges below are approximate and vary from person to person:

  • Cocaine (as its metabolite): roughly 2 to 4 days after use.
  • Methamphetamine and amphetamines: roughly 2 to 4 days.
  • Short-acting opioids such as heroin or morphine: roughly 1 to 3 days.
  • Cannabis: a few days after occasional use, and potentially several weeks after heavy daily use.
  • Benzodiazepines: days to weeks, depending on whether the medication is short- or long-acting.

Alcohol itself clears quickly, so programs often use a breathalyzer on arrival and may use a separate lab test that looks for alcohol byproducts over a longer window. If you drank on the way to admission, say so. Nobody is trying to catch you out, and the nursing team needs an accurate starting point to time withdrawal monitoring.

Testing During the Stay

After admission, most residential programs test at random intervals and sometimes after a pass or family outing. The purpose is the same as on day one: to keep the treatment plan honest and safe. A positive result mid-stay does not automatically end treatment at most programs. More often it leads to a clinical review, a conversation with the primary therapist, and an adjusted plan. Policies differ by facility, so ask for the written policy before you commit.

Residential treatment records are protected by federal confidentiality rules, and a drug test result is part of that record. A program generally cannot share results with an employer, a family member, or a court without your written consent, except in limited situations defined by law. If someone in your life needs proof of participation, you decide what is released and to whom.

Prescriptions and the Admission Test

Prescribed medications are one of the most common reasons for a confusing result. Gabapentin, buprenorphine, methadone, stimulants for ADHD, and benzodiazepines all show up differently depending on the panel. The fix is simple: bring the bottles in their original pharmacy labels, and give admissions a complete list before arrival. Our residential treatment team reconciles that list against the admission result so a legitimate prescription is never mistaken for misuse.

Do This Before You Call Admissions

Take ten minutes today and write down three things on one sheet of paper:

  1. Every substance you have used in the last 14 days, with the approximate amount and the date and time of the last use. Include alcohol, cannabis, and anything bought as a pill.
  2. Every prescription and over-the-counter medication you take, with the dose.
  3. Any past withdrawal seizures, hallucinations, or emergency visits related to withdrawal.

Then ask admissions these four questions: Does your admission panel include fentanyl? Do you test for buprenorphine and methadone separately? Are unexpected positives confirmed by a lab before any decision is made? What happens clinically if I test positive during the stay? Clear answers to those questions tell you a lot about how a program thinks about safety. You can call us at (877) 328-1968 to go through them with an admissions coordinator, or verify your insurance benefits first.

A View From Inside Treatment

The most useful admission test is the one that matches what the person told us. When the written history and the urine result line up, the medical team can plan withdrawal care with confidence from the first hour. When they do not, the gap almost always comes from fear rather than dishonesty: fear of being judged, refused, or reported. Programs that work well with drug testing make it clear that the result is clinical information, that it stays in the confidential record, and that a positive is the starting point for care rather than a reason to deny it.

The most common surprise on admission day is a positive for fentanyl in someone who believed they were using only cocaine, methamphetamine, or a pill bought as a prescription medication. That result changes the medical plan, so it is worth knowing about before arrival. It is also a strong reason for every family to keep naloxone at home, as recommended by the CDC.

If you are planning an admission and want to talk through what testing will look like for you, call (877) 328-1968. You can also read more about the clinical perspective behind this guide from Jonathan Beazley.

This article is for educational purposes only and is not medical advice. Detection windows and test performance vary by person and by laboratory. Do not stop alcohol, benzodiazepines, or other medications without medical supervision. If you or someone you know is in immediate danger, call 911. For a mental health or substance use crisis, call or text 988.

/by

Depression or Substance Use? How Co-Occurring Diagnoses Are Made in Residential Treatment, the One-Month Guideline, and What to Tell Admissions

, ,
Treatment for High Functioning Depression

Many people arrive at residential treatment carrying two questions at once: “Is my drinking or drug use the problem?” and “Or is it depression, anxiety, or something else underneath?” Families ask the same thing at admission, often hoping for a clear answer on day one. In practice, a responsible program usually cannot give a final psychiatric diagnosis that early, and the reason is clinical, not bureaucratic. This post explains how co-occurring mental health conditions are evaluated during residential treatment, why the timing matters, and what to tell admissions so the evaluation starts on the right footing.

Why a Psychiatric Diagnosis Often Waits Until After Withdrawal

Alcohol, stimulants, opioids, cannabis and sedatives all change mood, sleep, appetite and concentration, both during heavy use and during withdrawal. Someone coming off methamphetamine can look severely depressed for days. Someone in early alcohol withdrawal can look like they have a panic disorder. Those symptoms are real and they are treated, but they do not yet tell a clinician whether an independent depressive or anxiety disorder exists.

When a diagnosis of depression can be separated from substance use: Under the DSM-5 diagnostic criteria, a depressive episode that starts during intoxication or withdrawal is generally classed as substance-induced, and clinicians look for symptoms that persist for a substantial period, about one month, after acute withdrawal or heavy intoxication ends before treating it as an independent disorder. A documented history of depression during earlier periods of sobriety also counts as evidence of an independent condition. That is why a residential program will usually describe early mood symptoms as provisional and revisit the diagnosis after the first few weeks of abstinence.

The paragraph above is the single most useful thing for families to understand. “We are watching it” in week one is not avoidance; it is how the diagnostic criteria are designed to work.

What Week One Actually Looks Like

The first week of residential care is usually dominated by sleep and physical stabilization. It is common for mood to dip partway through that first week, when the immediate relief of being in a safe place has worn off and the body is still recalibrating. Families who call during that window sometimes hear a loved one say “this isn’t working” or “I think I’ve always been depressed.” Both statements deserve to be taken seriously and passed on to staff, and both are common at that point in care.

By the second and third weeks, the picture often shifts. Sleep starts to regulate, appetite returns, and the person can engage in therapy groups with more focus. This is when clinicians get a clearer read on what is left once the substance effects have faded. For some people, the depression lifts substantially. For others, it stays put, and that persistence is itself diagnostic information.

Common Reasons Mood Symptoms Persist in Early Recovery

When low mood or anxiety continues past early withdrawal, clinicians typically consider several possibilities:

  • Independent depressive or anxiety disorder: A condition that existed before or alongside substance use and needs its own treatment plan.
  • Protracted withdrawal symptoms: Some people experience lingering sleep disturbance, irritability and low mood for weeks after stopping alcohol, opioids or benzodiazepines.
  • Trauma-related symptoms: Substance use sometimes masks post-traumatic stress symptoms that surface once the person is sober.
  • Grief and consequences: Lost relationships, legal problems and financial damage produce real sadness that is not always a disorder.
  • Medication effects or gaps: Psychiatric medications that were taken inconsistently during active use may need to be reassessed.

The National Institute on Drug Abuse (NIDA) describes substance use disorders and other mental illnesses as frequently occurring together and recommends that both be assessed and treated in an integrated way rather than one after the other. The National Institute of Mental Health (NIMH) makes a similar point about shared risk factors.

What Families Usually Notice First

Families often have the most valuable information in the room. They remember whether a loved one seemed withdrawn as a teenager before any drinking started, whether panic attacks came first or later, and whether there were long stretches of sobriety that were still hard emotionally. That timeline is exactly what a clinician needs to separate substance-induced symptoms from an independent disorder. Before the intake or family session, it helps to write down approximate dates rather than relying on memory in the moment.

Psychiatric Medications at Admission: What Happens to Them

People entering treatment are sometimes afraid that their antidepressant or other psychiatric medication will be stopped. In general, medications that were prescribed and taken as directed are reviewed by the medical team and continued unless there is a clinical reason to change them. Do not stop an antidepressant, mood stabilizer or antipsychotic on your own before admission; abrupt discontinuation of some of these medications can cause significant withdrawal effects or a return of symptoms.

Benzodiazepines are a separate case. Stopping benzodiazepines suddenly, like stopping alcohol after heavy daily use, can cause seizures and can be life-threatening. Withdrawal from either must be medically supervised. Tell admissions the exact dose and how long you have been taking it so the medical team can plan a safe taper.

What to Tell Admissions Before You Arrive

Here is a step you can take today: before your admissions call, write down and bring the following, ideally on one page:

  1. Every current medication: Name, dose, prescriber and the date you last took it, including anything taken irregularly.
  2. Past diagnoses: Any mental health diagnosis you have been given, by whom, and roughly when.
  3. Sober-period history: Whether depression, anxiety or panic were present during any stretch of 30 days or more without alcohol or drugs.
  4. Past hospitalizations or crisis care: Including any psychiatric holds or emergency visits.
  5. Current safety concerns: Any recent thoughts of suicide or self-harm, even if they have passed.

Then ask admissions three specific questions: “Who on your team does the psychiatric evaluation, and when in the stay does it happen?” “How often is the diagnosis revisited after withdrawal?” and “How will mental health care continue after discharge?” A program that offers integrated mental health treatment should be able to answer all three without hesitation.

If you would like to talk this through before admission, call our team at (877) 328-1968.

How Co-Occurring Care Fits Into Residential Treatment

In residential treatment, integrated care usually means the same team is watching both the substance use and the mental health picture day to day. Therapy groups address cravings and relapse prevention alongside mood regulation, sleep, and anxiety skills. Individual sessions give room to work on trauma or grief once the person is stable enough. The psychiatric provider adjusts medications based on how symptoms evolve rather than on a single snapshot from intake.

Insurance coverage for co-occurring care varies by plan. If cost is a concern, you can verify your insurance benefits before admission so there are no surprises about psychiatric services.

After Discharge: Keeping the Diagnosis Accurate

A diagnosis made in residential treatment is a working diagnosis. It should travel with the person to their outpatient therapist and prescriber, who can confirm or revise it as sobriety continues. Ask for a written summary of the psychiatric evaluation and current medications at discharge, and bring it to the first outpatient appointment. The SAMHSA National Helpline can help locate continuing care if you are moving to a different area.

When Symptoms Are an Emergency

If you or someone you love is thinking about suicide or is in immediate danger, call or text 988 to reach the 988 Suicide and Crisis Lifeline, or call 911. Do not wait for an admissions appointment.

For questions about residential treatment for co-occurring substance use and mental health conditions in Northern California, call Bodhi Addiction Treatment at (877) 328-1968.

This article is for educational purposes only and is not a substitute for professional medical or psychiatric advice, diagnosis, or treatment. Always consult a qualified healthcare provider about your specific situation. Never stop or change a prescribed medication without medical guidance.

/by

When a Loved One Refuses Treatment in California: 5150 Holds, SB 43, and What Families Can Do

, ,
Pexels Tara Winstead 8383491 — Bodhi Addiction Treatment & Wellness

The call usually comes late in the evening. A parent or spouse has watched someone they love decline for months, has asked them to get help more times than they can count, and has just heard the same answer again: no. What they want to know next is practical. Can anyone make this person go to treatment in California? Who decides, how long does it last, and what happens afterward?

This guide walks through the legal tools that exist in California, what each one actually does, and what families can do today when a loved one refuses residential treatment. It is written from the admissions and intervention side of this work, where we see what happens after a hold ends, not just how it begins.

The Short Answer: What California Law Allows

In California, an adult who refuses substance use treatment generally cannot be placed in a residential addiction program against their will. Residential treatment is voluntary: the person has to consent to admission. What California law does allow is a 5150 hold under the Welfare and Institutions Code, which lets a peace officer or a county-designated professional detain a person for up to 72 hours of psychiatric evaluation and crisis care if they are a danger to themselves or others, or gravely disabled. Since Senate Bill 43, grave disability can now be based on a severe substance use disorder alone, and every county has been required to apply that expanded definition since January 1, 2026. A hold is an evaluation, not a treatment placement, so families should plan for what happens when the 72 hours end.

The Legal Tools, Step by Step

5150 hold (up to 72 hours): An involuntary hold for evaluation and crisis intervention at a designated facility, started by law enforcement or a county-designated clinician, not by a family member directly.

5250 certification (up to 14 days): If the facility believes the person still meets criteria at the end of the hold, it can certify them for intensive treatment, which triggers a certification review hearing.

LPS conservatorship: A court process, usually initiated by the county, for people who remain gravely disabled. It is a serious legal step that removes significant decision-making rights, and it is reserved for the most severe situations.

CARE Court: California’s CARE Act process, statewide since December 2024, is limited to people with schizophrenia spectrum or other psychotic disorders. A substance use disorder by itself does not qualify, which surprises many families who have read about it in the news.

None of these is a referral to a rehab program. Each is a crisis or court process run by county behavioral health and the hospital system.

What SB 43 Changed, and What It Did Not

SB 43 was signed in 2023 and took effect on January 1, 2024, with counties allowed to delay implementation until January 1, 2026. It made two changes that matter to families. First, it allows grave disability to be based on a severe substance use disorder, or a substance use disorder occurring alongside a mental health condition. Second, it broadened the definition so that a person can be found gravely disabled if they cannot provide for their own personal safety or necessary medical care, not only food, clothing, and shelter.

What SB 43 did not do is create a pathway from a hold into a residential addiction program. The law widened who can be evaluated. It did not change the fact that a residential program needs the person’s agreement to admit them, or the reality that local inpatient psychiatric and detox capacity is limited.

Why a Hold Often Ends Without Treatment

Families are sometimes told that a 5150 will “get them into rehab.” In practice, there are several reasons it often does not.

Evaluation, not placement: The hold exists to stabilize and assess a crisis, and once acute intoxication or withdrawal resolves, the person may no longer meet the legal criteria.

The clock runs on the facility’s schedule: Release can happen at any hour once the person no longer meets criteria, sometimes before family has been told.

Confidentiality limits what you hear: Without written consent from the patient, staff may not be able to confirm that your loved one is there at all.

No bed is being held: Unless someone has already lined up a voluntary program and verified insurance, there is nowhere ready to go at discharge.

The inconvenient truth we see from the admissions side is that the most useful window is often the hours right after a hold ends, when the person is sober, frightened, and briefly open to a different answer. Families who have already done the paperwork for a program are the ones who can act in that window.

What You Can Do Today

If there is immediate danger, call 911. For a mental health or substance use crisis that is not a medical emergency, call or text 988, the Suicide and Crisis Lifeline, which can connect you to local mobile crisis services. Short of a crisis, these are concrete steps a family can take this week:

  1. Write a one-page fact sheet now. List the substances used, roughly how much each day, the date and time of last known use, current prescriptions, medical conditions, and any statements about self-harm. Hand a copy to responding officers, crisis workers, or ER staff. Specific facts help clinicians decide whether criteria are met.
  2. Flag alcohol and benzodiazepine use clearly. Withdrawal from alcohol or benzodiazepines can cause seizures and can be life-threatening. It requires medical supervision. If your loved one drinks daily or takes benzodiazepines, say so first, in writing, to anyone treating them.
  3. Call your county behavioral health access line and ask two questions: “Who in this county can initiate a 5150 evaluation, and is there a mobile crisis team?” and “Who handles conservatorship investigations if someone is repeatedly gravely disabled?”
  4. Line up the voluntary option before you need it. Verify insurance benefits for residential treatment now, so a bed can be discussed the same day your loved one says yes. Our admissions team can talk this through at (877) 328-1968.

SAMHSA’s National Helpline at 1-800-662-4357 is free, confidential, and available 24 hours a day, 365 days a year for treatment referrals and information.

When Legal Tools Do Not Fit: Structured Intervention

Most families are not facing a situation that meets the legal criteria for a hold. Their loved one is still working, still functioning in some ways, and still saying no. For these families, the more realistic path is a planned conversation with clear boundaries, often guided by a trained interventionist.

A structured intervention is not an ambush. It works best when the family has agreed in advance on what they will say, what they will stop doing, and which program is ready to admit the person that day. A professional addiction interventionist can help a family plan that conversation, prepare for refusal, and avoid the common mistake of issuing consequences no one intends to keep.

The research on addiction treatment supports persistence. The National Institute on Drug Abuse describes addiction as a treatable condition and notes that treatment does not need to be voluntary at the outset to be effective; outside pressure from family, employers, or the legal system can help a person engage. That does not mean pressure works every time. It means a “no” today is not the final answer.

Taking Care of Yourself While You Wait

Family members often carry this alone for a long time. Support groups for families, individual counseling, and education about substance use disorders can reduce isolation and help you hold boundaries without giving up on the relationship. SAMHSA’s help and referral resources are a reasonable place to start, and the National Institute on Alcohol Abuse and Alcoholism offers plain-language guidance if alcohol is the primary concern.

Talk to Someone Who Does This Every Day

If your loved one is refusing treatment and you are not sure which of these options fits, a confidential conversation can help you sort out what is a crisis, what is a planning problem, and what can be done this week. Bodhi Addiction Treatment provides residential drug and alcohol treatment in Northern California, and our team can walk you through admissions, insurance, and intervention options. Call (877) 328-1968.

This article is for educational purposes only and is not legal or medical advice. Laws and county procedures change, and how they apply depends on the specific facts. Consult an attorney or your county behavioral health department about legal options, and a qualified clinician about medical care. If someone is in immediate danger, call 911. For a mental health or substance use crisis, call or text 988.

/by

Bringing Your Prescriptions to Residential Treatment: Medication Reconciliation, Controlled Medications, and What to Tell Admissions

, ,
Mental Health Treatment | Bodhi Addiction & Wellness

Most people calling about residential treatment ask about insurance, length of stay and what to pack. Far fewer ask the question that most often causes a problem on admission day: what happens to the medications I already take? Blood pressure pills, an antidepressant, an inhaler, a stimulant for ADHD, a sleep aid, a benzodiazepine prescribed years ago. Every one of them has to be accounted for before the first night, and the process that does it has a name: medication reconciliation.

This guide explains how that process works in a residential setting, why controlled prescriptions are handled differently, and exactly what to have ready before you call admissions.

What Medication Reconciliation Means in Residential Treatment

Medication reconciliation in residential addiction treatment is the process of comparing every medication a person reports taking, including prescriptions, over-the-counter products and supplements, against pharmacy records and prescriber information, so the medical team can decide on the first day which medications continue unchanged, which are adjusted, which are tapered under supervision, and which are paused. It is completed at intake and repeated at discharge, and it depends heavily on how complete and accurate the list the person brings with them is.

In practice, the medical team is answering four questions for each item: Is it actually prescribed to this person? Is it being taken as prescribed? Does it interact with withdrawal management or with medications for addiction treatment? And is stopping it suddenly safe?

Why Controlled Prescriptions Get a Closer Look

Most routine medications, such as those for blood pressure, thyroid, diabetes or asthma, simply continue. The closer review is reserved for medications that can cause dependence or that change how withdrawal behaves.

Benzodiazepines: stopping them abruptly after regular use can cause seizures, so any change must be a supervised taper, never a sudden stop.

Opioid pain medications: combined with benzodiazepines or alcohol they raise the risk of dangerously slowed breathing, which affects how both are managed.

Stimulants prescribed for ADHD: the team weighs the documented diagnosis against current substance use before deciding whether to continue, adjust or pause.

Sleep medications and sedating supplements: these can stack with withdrawal medications and with each other, so the full list matters, including products bought without a prescription.

The U.S. Food and Drug Administration (FDA) has addressed the risks of benzodiazepine and opioid prescriptions directly. In August 2016 it required boxed warnings, its most prominent safety label, on opioid and benzodiazepine products about the dangers of using them together. In September 2020 it required the boxed warning on all benzodiazepines to be updated to describe the risks of misuse, addiction, physical dependence and withdrawal reactions. Those two dated label changes are a large part of why residential addiction treatment programs handle these prescriptions with extra care rather than continuing them automatically. The National Institute on Drug Abuse (NIDA) also publishes plain-language information on prescription medication misuse that families may find useful.

A Safety Point That Overrides Everything Else

If you or your loved one drinks heavily every day, or takes a benzodiazepine daily, do not stop on your own in the days before admission to “get a head start.” Withdrawal from alcohol and from benzodiazepines can cause seizures and, in severe cases, can be life-threatening. Medical supervision is required. The safest plan is usually to continue as you are, report your use honestly, and let the medical team manage the transition. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) describes alcohol withdrawal as a condition that can require medical treatment, and the American Society of Addiction Medicine (ASAM) publishes clinical guidelines for managing it.

If you are unsure whether it is safe to wait until admission, call us at (877) 328-1968 and ask to speak with someone about it before you change anything.

What We See Go Wrong on Admission Day

From years of admissions work in Northern California, the medication problems we see are rarely dramatic. They are logistical, and almost all of them are preventable:

  • Pills in a pill organizer or a plastic bag. Medications that are not in the original pharmacy-labeled container usually cannot be identified and verified, so they cannot be given until a replacement is obtained. That can mean a delay of a day or more for a medication the person depends on.
  • A list from memory. People commonly forget the inhaler, the eye drops, the once-weekly injection, or the supplement they take every night. Each omission is a gap in the medical picture.
  • Prescriptions from several prescribers. When a primary care doctor, a psychiatrist and a pain specialist each prescribe something, no single office has the whole list. The treatment team may be the first to see it all together.
  • Underreporting use. Saying “two drinks a night” when it is closer to a bottle, or “as prescribed” when it is twice the dose, does not change what the body will do in withdrawal. It only means the plan is built on the wrong numbers.

None of these reflect badly on the person. They are what happens when someone is preparing for treatment under stress. They are also easy to fix in advance.

What to Do Before You Call Admissions

Here is a short checklist you can complete today, before the admissions call or before admission day:

  1. Gather every bottle. Put every prescription, over-the-counter medication and supplement you have taken in the last 30 days on one table, in its original labeled container.
  2. Write one list. For each item, write the name, the dose, how often you actually take it, the prescriber, and the pharmacy. “Actually” matters more than “supposed to.”
  3. Call your pharmacy. Ask for a printed medication history. Most pharmacies can provide one, and it often catches items people forget.
  4. Flag the controlled ones. Circle anything that is a benzodiazepine, an opioid, a stimulant or a sleep medication, and note how long you have taken it.
  5. Ask these three questions on the admissions call: “Which of my medications will continue on day one?” “If a medication needs to be tapered, who sets the schedule?” “If something I take is not continued, will my prescriber be told?”

Bring the list, the bottles and the pharmacy printout on admission day. Admissions can tell you about any program-specific rules, such as how medications are stored and dispensed. You can start that conversation at (877) 328-1968.

What Happens After Intake

Once the medical team has the list, decisions are typically made in the first hours or day. Continued medications are usually stored and dispensed by staff rather than kept by the person. Medications that are tapered follow a written schedule. If a medication for addiction treatment, such as buprenorphine or naltrexone, is part of the plan, it is checked against everything else on the list first.

Reconciliation happens again at discharge. That second pass is just as important: the person should leave with a single, current list, a clear note on anything that was changed and why, and confirmation that the outpatient prescriber has been informed. If you are planning the step after residential care, our pages on partial hospitalization and outpatient treatment explain how care typically continues. You can also read about our approach to residential treatment.

For Families Helping With Preparation

Families often end up doing the practical work: collecting bottles from the bathroom cabinet, calling the pharmacy, finding the psychiatrist’s phone number. That help is valuable. It works best when the person entering treatment is part of it, because only they know what they actually take and how often. If your loved one is reluctant to share details with you, encourage them to share them directly with admissions instead. The goal is an accurate list, not who compiles it.

For confidential, free help finding treatment and support at any hour, the SAMHSA National Helpline is available 24 hours a day, 365 days a year, at 1-800-662-4357. If you or someone you love is in crisis or thinking about suicide, call or text 988. In an emergency, call 911.

Talk to Bodhi Before You Change Anything

If you are preparing for residential treatment and are unsure what to do with a current prescription, the most useful step is a conversation before admission, not on the day. Call Bodhi Addiction Treatment at (877) 328-1968 to talk through your medications, your use and what to bring.

This article is for educational purposes only and is not medical advice. Do not start, stop or change any medication without guidance from a qualified healthcare provider. Withdrawal from alcohol or benzodiazepines can be dangerous and requires medical supervision.

/by

Leaving Residential Treatment Against Medical Advice: What Happens, the First 24 Hours, and What to Ask For Before You Go

, ,
Capitola Beach — Bodhi Addiction Treatment & Wellness

Most people who think about leaving residential treatment early do it in the first week, often between day three and day seven. Withdrawal is easing, sleep is still broken, the novelty has worn off, and a voice says, “I’m fine now. I can do the rest at home.” Families get the phone call that starts with “Come pick me up.”

This guide explains what actually happens when someone leaves residential treatment against medical advice (AMA), why the first 24 hours afterward carry real medical risk, and the specific things to ask for before walking out the door. It is written from the admissions and clinical side of residential care in Northern California, where these conversations happen every week.

What “Against Medical Advice” Means in Residential Treatment

Leaving against medical advice means a person ends their stay before the treatment team recommends discharge. For an adult who admitted voluntarily, residential treatment is not a locked setting, and the program generally cannot hold someone who chooses to leave. What staff can do is slow the moment down, make sure the person is medically safe to go, and send them out with a plan instead of nothing.

In practice, an AMA discharge usually involves a conversation with a counselor or clinical lead, a check with medical staff about current withdrawal status and medications, and a form acknowledging that discharge is against the team’s recommendation. Signing that form does not erase the person’s record or bar them from coming back. It documents that the risks were explained.

Why People Leave Early: The Common Triggers

The reasons people give for leaving are usually not the real reasons. In residential work, the same handful of pressures show up again and again:

  • Post-acute withdrawal discomfort: Poor sleep, irritability, and low mood can linger for days or weeks after acute withdrawal ends, and they feel like proof that treatment “isn’t working.”
  • Cravings that peak without warning: A craving can arrive as a sudden, urgent certainty that leaving is the only reasonable choice, then fade within hours if the person stays put.
  • Outside pressure: A partner, employer, landlord, or court date creates a deadline that feels more pressing than the remaining days of care.
  • Conflict on the unit: A disagreement with a peer or staff member turns into “this place isn’t right for me.”
  • Feeling better too fast: Once the fog lifts, it is easy to mistake physical stabilization for recovery and conclude the job is done.

Naming the trigger matters, because most of them have a fix that does not require leaving: a medication adjustment, a room change, a call with the employer, a family session.

The Medical Risks in the First 24 Hours After Leaving

Leaving early is not only a setback in progress. Depending on the substance, it can be physically dangerous.

Alcohol and benzodiazepines: If someone leaves while still in withdrawal from alcohol or partway through a benzodiazepine taper, they can develop seizures and other serious complications. Withdrawal from either should only happen under medical supervision. Stopping a taper abruptly, or drinking to “take the edge off” after leaving, can make things worse. If a person who has left shows confusion, shaking, hallucinations, or a seizure, call 911.

Opioids and lost tolerance: After even a short period without opioids, tolerance drops. Returning to a previous amount, especially in a drug supply that may contain fentanyl, can cause an overdose. According to the National Institute on Drug Abuse (NIDA), naloxone can rapidly reverse an opioid overdose and quickly restore normal breathing, and it is available as a prepackaged nasal spray that requires no assembly.

Interrupted medications: People leaving mid-stay may be partway through starting buprenorphine, a psychiatric medication, or a medication for alcohol use disorder. Leaving without a prescription or a follow-up appointment can create a gap at the worst possible time.

Before You Walk Out: Five Things to Ask For Today

If you or someone you love has decided to leave residential treatment early, these five requests take less than an hour and can be the difference between a rough week and an emergency. Ask the staff, in this order:

  1. A medical check before you go. Ask the nurse or medical provider, “Am I medically safe to leave today, and what symptoms should send me to the ER?” Write the answer down.
  2. Your current medication list and prescriptions. Ask for printed copies of every medication, dose, and the next scheduled dose, plus prescriptions or a bridge supply where appropriate.
  3. Naloxone, if opioids are part of the history. Ask for a naloxone kit to take home, and make sure someone in the household knows where it is kept.
  4. A next appointment, not a phone number. Ask staff to book a specific date and time with an outpatient provider, a partial hospitalization program, or an outpatient program before you leave the building.
  5. The readmission question. Ask directly, “If I change my mind in a day or a week, what is the process to come back?” Knowing the door is open makes it easier to walk back through it.

A practical step for families: if your loved one calls asking to be picked up, ask them to wait 30 minutes and talk to their counselor first, then call the program yourself. Many urges to leave pass in that window.

What Families Can Do When the “Come Get Me” Call Comes

That phone call is hard. You want your loved one to be comfortable, and you also know what happened the last time they came home early. A few things help:

  • Stay calm and ask what happened today, rather than arguing about leaving.
  • Tell them you love them and that you support them finishing treatment.
  • Ask whether they have talked with their counselor or the medical team yet.
  • If they leave anyway, focus on safety: naloxone in the house, a follow-up appointment on the calendar, and a clear plan for what you will do if symptoms of withdrawal or overdose appear.

Families can also call our admissions team for guidance on how to handle the conversation, even if the person is in treatment somewhere else. Reach us at (877) 328-1968.

Free Help Is Available at Any Hour

Leaving residential treatment early does not end the option of getting help. SAMHSA’s National Helpline, 1-800-662-HELP (4357), is a free, confidential treatment referral and information service that operates 24 hours a day, 365 days a year, in English and Spanish, for individuals and families facing mental health or substance use disorders, according to the Substance Abuse and Mental Health Services Administration (SAMHSA). If someone has left treatment and is struggling at 2 a.m., that line is answered.

If someone is in immediate danger or is having thoughts of suicide, call or text 988 or call 911.

Leaving Is Not the End of the Story

An AMA discharge is common, and it is not a moral failure. Many people who leave early come back, sometimes within days, and do well the second time because they understand what they are walking into. What matters most is that the person leaves with a medical check, their medications, naloxone where relevant, and a real appointment, and that everyone knows how to come back.

If you are weighing whether to leave treatment, or trying to help someone who already has, talk to us first. Call (877) 328-1968 to speak with our admissions team about next steps, readmission, or a lower level of care that fits where you are now.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Withdrawal from alcohol or benzodiazepines can cause seizures and requires medical supervision. Always talk with a qualified healthcare provider about your specific situation. If you are experiencing a medical emergency, call 911.

/by

Nicotine in Residential Treatment: Smoking Policies, the Seven FDA-Approved Quit Medications, and What to Ask Admissions

, ,
Peaceful natural setting representing mindfulness practice in addiction recovery

Almost every admissions call eventually gets to the same question, usually asked a little sheepishly: “Can I smoke there?” or “Can I bring my vape?” It sounds like a small logistics detail next to detox and insurance. In practice, nicotine shapes the first week of residential treatment more than most people expect, and a plan for it, made before admission day, removes one of the most common reasons people feel like leaving early.

This guide covers how nicotine is usually handled in residential drug and alcohol treatment, which medications exist, how nicotine withdrawal overlaps with other withdrawal, and the specific questions to ask admissions before you arrive.

Why Nicotine Belongs in the Treatment Plan

Tobacco and nicotine use are far more common among people with substance use disorders than in the general population, a pattern documented by the National Institute on Drug Abuse (NIDA). For a long time, many programs treated cigarettes as the one habit to leave alone during recovery, on the theory that quitting everything at once was too much. That view has shifted. Federal guidance from SAMHSA encourages behavioral health programs to address tobacco as part of care rather than set it aside, and research summarized by NIDA generally suggests that working on nicotine during addiction treatment does not undermine recovery from other substances and may support it.

That does not mean anyone is required to quit nicotine the day they walk in. It means nicotine is a clinical question that deserves an answer in the admission plan, the same way sleep, medications, and withdrawal do.

The Seven FDA-Approved Quit Medications

The U.S. Food and Drug Administration has approved seven medications to help people quit smoking, according to the Centers for Disease Control and Prevention (CDC): five forms of nicotine replacement (the patch, gum, lozenge, inhaler, and nasal spray) and two non-nicotine prescription pills, varenicline and bupropion. A person entering residential treatment in California can ask admissions which of these seven the program can continue, order, or start on site, and whether a combination such as a patch plus gum or lozenges is used, since pairing a long-acting and a short-acting form is a common clinical approach.

A few practical points about these medications in a residential setting:

  • Nicotine replacement can start on day one. Patches and gum do not require a quit date to be set in advance, which makes them the most common option during the first days of a stay.
  • Varenicline and bupropion take time to build. Both are typically started before a planned quit date rather than on it. The prescribing clinician sets the schedule, so this is worth raising early in a stay rather than the week before discharge.
  • Bupropion needs a medical review. It is not appropriate for everyone, including people with a seizure history or those currently withdrawing from alcohol or sedatives. That decision belongs to the medical team.
  • Insurance and cost vary. Coverage for quit medications differs by plan. When you verify your insurance, it is reasonable to ask whether tobacco cessation medications are covered.

Why Nicotine Withdrawal Gets Confused With Everything Else

One of the most useful things we see in the first week is simply naming what is nicotine. People arrive already dealing with withdrawal from alcohol, opioids, stimulants, or sedatives. If their nicotine intake also drops sharply because smoking is limited to set times and places, a second withdrawal stacks on top of the first, and the two are hard to tell apart from the inside.

The overlap is real. Nicotine withdrawal commonly brings these, often within the first few days of cutting down:

  • Irritability: a short fuse that often gets read as “treatment isn’t working” or “I don’t belong here.”
  • Restlessness and poor concentration: the same complaints people have during early alcohol or stimulant withdrawal, which makes groups feel unbearable.
  • Sleep disruption: already common in early recovery, and nicotine changes can make it worse.
  • Cravings that blur together: an urge for a cigarette and an urge for the primary substance can feel like one undifferentiated “I need something.”

The practical consequence is that someone can decide to leave treatment over discomfort that a nicotine patch would have eased. In our experience, asking “When did you last have nicotine, and how much do you usually use in a day?” is one of the most clarifying questions on intake, and it often changes the plan for the first 72 hours.

An important safety note: nicotine withdrawal is uncomfortable but not medically dangerous. Withdrawal from alcohol or benzodiazepines is different and can cause seizures. If you are stopping alcohol or a benzodiazepine, medical supervision is required. Do not reduce or stop those substances on your own before admission without speaking to a medical provider. Our residential treatment program coordinates withdrawal management with medical staff for exactly this reason.

Smoking, Vaping, and House Rules

Policies differ widely between residential programs in California. Some allow smoking in a designated outdoor area at set times. Some are entirely tobacco-free on the property. Many restrict vapes specifically, because cartridges are easy to refill with substances other than nicotine and are hard for staff to check. None of these policies is wrong, but finding out about them on admission day, without a replacement plan, is how people end up miserable in week one.

Families also notice something worth knowing: smoke breaks become social. In programs that allow them, the smoking area is often where people talk most openly. That is not a reason to keep smoking, but it explains why people resist giving it up in the middle of treatment, and why a plan that respects that reality tends to work better than an ultimatum.

What to Do Before Admission Day

Here is a short check you can run this week if you or a family member is preparing for residential treatment.

  1. Write down your actual daily nicotine use. Cigarettes per day, vape pods per day, or pouches per day, plus how soon after waking you use. These numbers are what the medical team uses to choose a replacement dose.
  2. Ask admissions three specific questions: Is the property tobacco-free, or is smoking allowed in a designated area? Are vapes permitted, and if not, what happens to one I bring? Which nicotine replacement products or quit medications can you provide on day one?
  3. Ask whether nicotine is addressed in the treatment plan. You are not committing to quit by asking. You are making sure someone has thought about it.
  4. Do not stockpile. Bringing cartons or extra vapes usually results in them being held at intake. Bring the information instead.

If you want help working through these questions, call our admissions team at (877) 328-1968. We can tell you how nicotine is handled on site and what medication options are available before you commit to a date.

After Discharge: Keeping Nicotine in the Plan

Whatever someone decides about nicotine during a residential stay, the decision should carry into the discharge plan. If a person started nicotine replacement or a prescription quit medication in treatment, the discharge paperwork should say which product, what dose, and who will continue prescribing it. Gaps in that handoff are common, and a person who runs out of patches in the second week home is facing nicotine withdrawal at the same moment they are adjusting to life outside a structured setting.

Free telephone coaching is available nationally through 1-800-QUIT-NOW, which connects callers to their state quitline, as described by the CDC. Adding that number to the discharge plan costs nothing and gives the person a resource that is available beyond office hours.

A Note From Clinical Practice

As a counselor and interventionist, I have watched nicotine decide more admissions than most people would believe. The person who is ready to stop drinking but cannot picture three weeks without a cigarette will sometimes delay treatment over that one fear. A clear, honest answer about nicotine policy and replacement options, given on the first phone call, removes the fear and keeps the focus where it belongs.

If you are weighing residential treatment for yourself or someone you love, reach out at (877) 328-1968. We will walk you through admissions, insurance, and what the first week will look like, including the nicotine question.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Medication decisions, including nicotine replacement and prescription quit medications, should be made with a qualified medical provider. Withdrawal from alcohol or benzodiazepines can be life-threatening and requires medical supervision. If you are in crisis, call or text 988 to reach the 988 Suicide & Crisis Lifeline, or call 911 in an emergency.

/by